Skip to main content

Deciphering the Conundrum of Estrogen-driven Breast Cancer: Aurora Kinase Deregulation

  • Conference paper
Hormonal Control of Cell Cycle

Part of the book series: Research and Perspectives in Endocrine Interactions ((RPEI))

  • 346 Accesses

Abstract

Of all cancers occurring in women in developed countries, breast cancer (BC) accounts for ~32%; obviously a world-wide public health concern. More than 90% of all breast cancer cases are sporadic/non-familial, and largely ductal carcinomas. Estrogens have a profound role in BC causation and progression. Although estrogen receptor α is an important characteristic of BC, it is not its most defining feature. Rather, its hallmark is chromosomal instability and aneuploidy. On the basis of our studies, we developed a new paradigm in a murine breast tumor model induced by near physiological estrogen levels that exquisitely resembles human ductal BC, both in its histopathologic and molecular progression. Estrogen-driven deregulation of the cell cycle and the mitotic machinery are crucial molecular events leading to BC in this estrogen-induced murine mammary tumor model and in women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adami HO, Persson I, Ekbom A, Wolk A, Ponten J, Trichopoulos D (1995) The aetiology and pathogenesis of human breast cancer. Mutat Res 333:29–35

    CAS  PubMed  Google Scholar 

  • Adnane J, Gaudray P, Simon MP, Simony-Lafontaine J, Jeanteur P, Theillet C (1989) Proto-oncogene amplification and human breast tumor phenotype. Oncogene 4:1389–95

    CAS  PubMed  Google Scholar 

  • Aldaz CM, Gollahon LS, Chen A (1992) Chromosome alterations in rat mammary tumor progression. Prog Clin Biol Res 376:137–153

    CAS  PubMed  Google Scholar 

  • Andrews PD, Knatko E, Moore WJ, Swedlow JR (2003) Mitotic mechanics: the auroras come into view. Curr Opin Cell Biol 15:672–683

    Article  CAS  PubMed  Google Scholar 

  • Becker K (1995) Principles and practice of endocrinology and metabolism. Ed 2. Lippincott Co, Philadelphia, PA

    Google Scholar 

  • Boveri T (1914) The origin of malignant tumours. Williams and Wikins, Baltimore

    Google Scholar 

  • Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11:18–21

    Article  CAS  PubMed  Google Scholar 

  • Brinkley BR, Goepfert TM (1998) Supernumerary centrosomes and cancer: Boveri’s hypothesis resurrected. Cell Motil Cytoskeleton 41:281–288

    Article  CAS  PubMed  Google Scholar 

  • Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F, Pasqualini JR (2000) Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72:23–27

    Article  CAS  PubMed  Google Scholar 

  • Clarke R, Leonessa F, Welch JN, Skaar TC (2001) Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53:25–71

    CAS  PubMed  Google Scholar 

  • Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276–285

    Article  CAS  PubMed  Google Scholar 

  • Colditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90:814–823

    Article  CAS  PubMed  Google Scholar 

  • Deming SL, Nass SJ, Dickson RB, Trock BJ (2000) C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 83:1688–1695

    Article  CAS  PubMed  Google Scholar 

  • Dubik D, Dembinski TC, Shiu RP (1987) Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47:6517– 6521

    CAS  PubMed  Google Scholar 

  • Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE (2006) Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman’s predicted breast cancer risk? J Clin Oncol 24:1823–1830

    Article  CAS  PubMed  Google Scholar 

  • Feigelson H, Henderson B (1996) Estrogens and breast cancer. Carcinogenesis 17:2279–2284

    Article  CAS  PubMed  Google Scholar 

  • Haag JD, Hsu LC, Newton MA, Gould MN (1996) Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Mol Carcinog 17:134–143

    Article  CAS  PubMed  Google Scholar 

  • Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, Lippman SM (2003) Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev 12:1518–1522

    CAS  PubMed  Google Scholar 

  • Janocko LE, Lucke JF, Groft DW, Brown KA, Smith CA, Pollice AA, Singh SG, Yakulis R, Hartsock RJ, Shackney SE (1995) Assessing sequential oncogene amplification in human breast cancer. Cytometry 21:18–22

    Article  CAS  PubMed  Google Scholar 

  • Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30

    Article  PubMed  Google Scholar 

  • Kong EH, Pike AC, Hubbard RE (2003) Structure and mechanism of the oestrogen receptor. Biochem Soc Trans 31:56–59

    Article  CAS  PubMed  Google Scholar 

  • Kramer A, Mailand N, Lukas C, Syljuasen RG, Wilkinson CJ, Nigg EA, Bartek J, Lukas J (2004) Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nature Cell Biol 6:884–891

    Article  PubMed  CAS  Google Scholar 

  • Li JJ, Li SA (2006) Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Pharmacol Ther 111:974–984

    Article  CAS  PubMed  Google Scholar 

  • Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, El-Bayoumy K, Ballenger J, Tawfik O, Li SA (2002) Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33:56–65

    Article  PubMed  CAS  Google Scholar 

  • Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA (2004) Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 101:18123–18128

    Article  CAS  PubMed  Google Scholar 

  • Li SA, Weroha SJ, Tawfik O, Li JJ (2002) Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175:297–305

    Article  CAS  PubMed  Google Scholar 

  • Lingle WL, Salisbury JL (2001) Methods for the analysis of centrosome reproduction in cancer cells. Methods Cell Biol 67:325–336

    Article  CAS  PubMed  Google Scholar 

  • Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL (1998) Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci USA 95:2950–2955

    Article  CAS  PubMed  Google Scholar 

  • Lingle WL, Barrett SL, Negron VC, D’Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL (2002) Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99:1978–1983

    Article  CAS  PubMed  Google Scholar 

  • Marumoto T, Zhang D, Saya H (2005) Aurora-A – a guardian of poles. Nat Rev Cancer 5:42–50

    Article  CAS  PubMed  Google Scholar 

  • Miyoshi Y, Iwao K, Egawa C, Noguchi S (2001) Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 92:370–373

    Article  CAS  PubMed  Google Scholar 

  • Naftolin F, Brown-Grant K, Corker CS (1972) Plasma and pituitary luteinizing hormone and peripheral plasma oestradiol concentrations in the normal oestrous cycle of the rat and after experimental manipulation of the cycle. J Endocrinol 53:17–30

    CAS  PubMed  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108 (5) Andrieu N, Prevost T, Rohan TE, Luporsi E, Le MG, Gerber M, Zaridze DG, Lifanova Y, Renaud R, Lee HP, Duffy SW (2000) Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol 29:214–223

    Google Scholar 

  • Petrizzi V, Cicatiello L, Altucci L, Addeo R, Borgo R, Cancemi M, Ancora M, Leyva J, Bresciani F (2001) Transcriptional control of cell cycle progression by estrogenic hormones: Regulation of human cyclin D1 gene promoter activity by estrogen receptor alpha. Springer-Verlag New York, Inc, New York, NY

    Google Scholar 

  • Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE (2000) Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer 82:1867–1870

    Article  CAS  PubMed  Google Scholar 

  • Sasai K, Katayama H, Stenoien DL, Fujii S, Honda R, Kimura M, Okano Y, Tatsuka M, Suzuki F, Nigg EA, Earnshaw WC, Brinkley WR, Sen S (2004) Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motil Cytoskeleton 59:249–263

    Article  CAS  PubMed  Google Scholar 

  • Salisbury JL (2001) The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer. J Mammary Gland Biol Neoplasia 6:203–212

    Article  CAS  PubMed  Google Scholar 

  • Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401:297–300

    Article  CAS  PubMed  Google Scholar 

  • Steeg PS, Zhou Q (1998) Cyclins and breast cancer. Breast Cancer Res Treat 52:17–28

    Article  CAS  PubMed  Google Scholar 

  • Sutherland RL, Musgrove EA (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9:95–104

    Article  PubMed  Google Scholar 

  • Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 59:2041–2044

    CAS  PubMed  Google Scholar 

  • Toniolo PG (1997) Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Environ Health Perspect 105 Suppl 3:587–592

    Article  PubMed  Google Scholar 

  • Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC (1986) Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22:515–525

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF (2005) Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun 336:1023–1027

    Article  CAS  PubMed  Google Scholar 

  • Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M, Gustafsson JA (2003) Update on estrogen signaling. FEBS Lett 546:17–24

    Article  PubMed  CAS  Google Scholar 

  • Weroha SJ, Li SA, Tawfik O, Li JJ (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27:491–498

    Article  CAS  PubMed  Google Scholar 

  • Xiong Y, Connolly T, Futcher B, Beach D (1991) Human D-type cyclin. Cell 65:691–699

    Article  CAS  PubMed  Google Scholar 

  • Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet 20:189–193

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Li, J., Li, S. (2008). Deciphering the Conundrum of Estrogen-driven Breast Cancer: Aurora Kinase Deregulation. In: Melmed, S., Rochefort, H., Chanson, P., Christen, Y. (eds) Hormonal Control of Cell Cycle. Research and Perspectives in Endocrine Interactions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73855-8_6

Download citation

Publish with us

Policies and ethics